SK146599A3 - Essentially pure or recombinant protein dtlr2-10, a fused protein, a bond substance, a nucleic acid, an expression vector, a host cell and process for their production - Google Patents

Essentially pure or recombinant protein dtlr2-10, a fused protein, a bond substance, a nucleic acid, an expression vector, a host cell and process for their production Download PDF

Info

Publication number
SK146599A3
SK146599A3 SK1465-99A SK146599A SK146599A3 SK 146599 A3 SK146599 A3 SK 146599A3 SK 146599 A SK146599 A SK 146599A SK 146599 A3 SK146599 A3 SK 146599A3
Authority
SK
Slovakia
Prior art keywords
protein
seq
dtlr
sequence
peptide
Prior art date
Application number
SK1465-99A
Other languages
English (en)
Slovak (sk)
Inventor
Gerard T Hardiman
Fernando L Rock
Fernando J Bazan
Robert A Kastelein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27366459&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK146599(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SK146599A3 publication Critical patent/SK146599A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SK1465-99A 1997-05-07 1998-05-07 Essentially pure or recombinant protein dtlr2-10, a fused protein, a bond substance, a nucleic acid, an expression vector, a host cell and process for their production SK146599A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4429397P 1997-05-07 1997-05-07
US7221298P 1998-01-22 1998-01-22
US7694798P 1998-03-05 1998-03-05
PCT/US1998/008979 WO1998050547A2 (en) 1997-05-07 1998-05-07 Human toll-like receptor proteins, related reagents and methods

Publications (1)

Publication Number Publication Date
SK146599A3 true SK146599A3 (en) 2000-07-11

Family

ID=27366459

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1465-99A SK146599A3 (en) 1997-05-07 1998-05-07 Essentially pure or recombinant protein dtlr2-10, a fused protein, a bond substance, a nucleic acid, an expression vector, a host cell and process for their production

Country Status (19)

Country Link
EP (4) EP1798288B1 (cg-RX-API-DMAC7.html)
JP (4) JP2002514083A (cg-RX-API-DMAC7.html)
KR (1) KR100388860B1 (cg-RX-API-DMAC7.html)
CN (4) CN1935840A (cg-RX-API-DMAC7.html)
AT (3) ATE443139T1 (cg-RX-API-DMAC7.html)
AU (1) AU740333B2 (cg-RX-API-DMAC7.html)
CA (1) CA2289912C (cg-RX-API-DMAC7.html)
CY (1) CY1109645T1 (cg-RX-API-DMAC7.html)
DE (3) DE69841514D1 (cg-RX-API-DMAC7.html)
DK (2) DK0980429T3 (cg-RX-API-DMAC7.html)
ES (3) ES2279572T3 (cg-RX-API-DMAC7.html)
ID (1) ID28299A (cg-RX-API-DMAC7.html)
IL (1) IL132614A0 (cg-RX-API-DMAC7.html)
NO (1) NO995458D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ338073A (cg-RX-API-DMAC7.html)
PL (1) PL336635A1 (cg-RX-API-DMAC7.html)
PT (1) PT1798288E (cg-RX-API-DMAC7.html)
SK (1) SK146599A3 (cg-RX-API-DMAC7.html)
WO (1) WO1998050547A2 (cg-RX-API-DMAC7.html)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8212004B2 (en) 1999-03-02 2012-07-03 Human Genome Sciences, Inc. Neutrokine-alpha fusion proteins
US6812327B1 (en) 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US7696327B1 (en) 1997-10-17 2010-04-13 Genentech, Inc. Antibodies to human Toll homologues
US20030032090A1 (en) 1997-05-07 2003-02-13 Schering Corporation, A New Jersey Corporation Human receptor proteins; related reagents and methods
AU2003203679B2 (en) * 1997-10-17 2007-04-05 Genentech, Inc. Human toll homologues
PT1650219E (pt) * 1997-10-17 2008-03-31 Genentech Inc Homólogos de toll humana
JP2000128900A (ja) * 1998-10-26 2000-05-09 Japan Science & Technology Corp 新規トル様(Toll−like)レセプター及びその遺伝子
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US6740487B1 (en) * 1999-06-10 2004-05-25 University Of Iowa Research Foundation Variant TLR4 nucleic acid and uses thereof
ATE421584T1 (de) * 1999-11-02 2009-02-15 Novartis Vaccines & Diagnostic Cpg rezeptor (cpg-r) und darauf bezogene methoden
GB9927332D0 (en) * 1999-11-18 2000-01-12 Leiv Eiriksson Nyfotek As Novel antibody and uses thereof
GB0001704D0 (en) * 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
US20030083244A1 (en) * 2000-04-26 2003-05-01 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
NZ522327A (en) * 2000-05-25 2004-09-24 Schering Corp Mammalian DNAX Toll-like receptor protein, DTLR 10, antibodies and medicaments made therefrom and use in treating immunological disorders
US7879328B2 (en) 2000-06-16 2011-02-01 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to B lymphocyte stimulator
NZ522700A (en) 2000-06-16 2006-02-24 Human Genome Sciences Inc Antibodies that immunospecifically bind to blys
JP2002034565A (ja) * 2000-07-19 2002-02-05 Japan Science & Technology Corp 細菌dnaを特異的に認識する受容体タンパク質
WO2002016411A2 (en) 2000-08-18 2002-02-28 Human Genome Sciences, Inc. Binding polypeptides and methods based thereon
EP2267018A3 (en) * 2000-08-18 2011-04-20 Human Genome Sciences, Inc. Binding polypeptides for B lymphocyte stimulator protein (BLyS)
JP2005500806A (ja) 2000-09-15 2005-01-13 コーリー ファーマシューティカル ゲーエムベーハー CpGに基づく免疫アゴニスト/免疫アンタゴニストの高スループットスクリーニングのためのプロセス
US7220723B2 (en) 2001-05-15 2007-05-22 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
CN1633598A (zh) * 2001-10-05 2005-06-29 科勒制药股份公司 Toll样受体3信号传导的激动剂和拮抗剂
US20040014779A1 (en) * 2001-11-16 2004-01-22 3M Innovative Properties Company Methods and compositions related to IRM compounds and toll-like recptor pathways
GB0127618D0 (en) * 2001-11-17 2002-01-09 Univ Nottingham "Composition and method for treatment of wounds"
JP2004016021A (ja) 2002-06-12 2004-01-22 Japan Science & Technology Corp 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット
AU2003287316A1 (en) * 2002-12-11 2004-06-30 3M Innovative Properties Company Assays relating to toll-like receptor activity
WO2004094671A2 (en) * 2003-04-22 2004-11-04 Coley Pharmaceutical Gmbh Methods and products for identification and assessment of tlr ligands
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CN1878793A (zh) 2003-09-11 2006-12-13 鉴定医疗有限公司 拮抗hmgb1的单克隆抗体
TW200514850A (en) * 2003-10-03 2005-05-01 Hitachi Chemical Co Ltd Method of evaluating risk for viral infection
WO2005032484A2 (en) 2003-10-03 2005-04-14 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
TW200516153A (en) * 2003-10-03 2005-05-16 Hitachi Chemical Co Ltd Human toll-like receptor 3 gene polymorphism as marker for inherited factor of allergic disease and utilization of the same
EP1697389A4 (en) 2003-10-24 2008-12-24 Eisai R&D Man Co Ltd COMPOUNDS AND METHODS FOR TREATING ILLNESS AND SUFFERING TOLL-LIKE RECEPTOR 2 RELATED DISORDERS
SG148201A1 (en) 2003-11-25 2008-12-31 3M Innovative Properties Co Substituted imidazo ring systems and methods
JP2008022701A (ja) * 2004-09-24 2008-02-07 Japan Science & Technology Agency 可溶型Toll様受容体4タンパク質
CA2587676A1 (en) 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
TWI487535B (zh) 2004-11-30 2015-06-11 Centocor Inc 類鐸受體3(toll like receptor3)拮抗劑,方法及用途
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
US7700728B2 (en) 2005-03-24 2010-04-20 Schering Corporation Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
US7498409B2 (en) 2005-03-24 2009-03-03 Schering Corporation Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
US9168286B2 (en) 2005-10-13 2015-10-27 Human Genome Sciences, Inc. Methods and compositions for use in treatment of patients with autoantibody positive disease
EP1945820B1 (en) 2005-10-27 2013-08-28 Janssen Biotech, Inc. Toll like receptor 3 modulators, methods and uses
EP2476432B1 (en) 2006-03-07 2015-08-19 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
WO2007123765A2 (en) 2006-03-31 2007-11-01 Human Genome Sciences Inc. Neutrokine-alpha and neutrokine-alpha splice variant
CN101134046B (zh) * 2006-09-01 2011-10-05 中国医学科学院药物研究所 Tlr4和tlr9激动剂复方在抑制肿瘤转移中的应用
US20080299138A1 (en) * 2007-05-25 2008-12-04 Duffy Karen E Toll-Like Receptor 3 Modulators and Uses Thereof
CA2722589A1 (en) 2008-04-25 2009-10-29 Innate Pharma Improved tlr3 agonist compositions
EP2116602A1 (en) 2008-05-07 2009-11-11 Institut Gustave Roussy Combination products for treating cancer
DK2334703T3 (en) 2008-09-17 2015-10-05 Innate Pharma Configurations and methods for detection of tlr3
US9512196B2 (en) 2008-09-22 2016-12-06 Cedars-Sinai Medical Center Short-form human MD-2 as a negative regulator of toll-like receptor 4 signaling
EP2328911A4 (en) 2008-09-22 2012-03-14 Cedars Sinai Medical Center SHORT HUMAN MD-2 AS A NEGATIVE REGULATOR OF GREAT LIKE RECEPTOR 4 SIGNALING
RU2562865C2 (ru) 2009-07-10 2015-09-10 Иннэйт Фарма Tlr3 связывающие агенты
JP5830744B2 (ja) * 2009-08-19 2015-12-09 国立大学法人東京工業大学 乳酸菌の付着性を誘導するペプチド及びその用途
WO2013054329A1 (en) * 2011-10-10 2013-04-18 Yeda Research And Development Co. Ltd. Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response
JP2013538558A (ja) 2010-07-19 2013-10-17 イエダ リサーチ アンド ディベロップメント カンパニー リミテッド Tlr媒介疾患を治療するためのtoll様受容体(tlr)の膜貫通型ドメインに基づくペプチド
WO2012088272A1 (en) 2010-12-21 2012-06-28 Duke University Methods and compositions combining immunotherapy with monocyte activation
WO2012095432A2 (en) 2011-01-12 2012-07-19 Innate Pharma Tlr3 binding agents
JP6093759B2 (ja) 2011-06-01 2017-03-08 ジャナス バイオセラピューティクス,インク. 新規の免疫系調節剤
ES2583877T3 (es) 2011-06-01 2016-09-22 Janus Biotherapeutics, Inc. Moduladores novedosos del sistema inmunitario
JP2014528449A (ja) 2011-10-04 2014-10-27 ジャナス バイオセラピューティクス,インク. 新規なイミダゾールキノリン系免疫系調節剤
WO2013178736A1 (en) 2012-05-31 2013-12-05 Innate Pharma Tlr3 binding agents
US10017739B2 (en) 2012-09-06 2018-07-10 Duke University Methods of expanding and assessing B cells and using expanded B cells to treat disease
CN113502299B (zh) * 2021-07-20 2023-03-14 中国农业大学 一种抗金黄色葡萄球菌遗传修饰山羊生产方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3645090A (en) 1969-06-19 1972-02-29 Citizen Watch Co Ltd Day-date quick-adjuster for calender timepiece
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
EP0912746A2 (en) * 1996-07-12 1999-05-06 Schering Corporation MAMMALIAN TNF-$g(a) CONVERTASES
DE69835751T2 (de) * 1997-08-01 2007-10-04 Serono Genetics Institute S.A. 5' ests für proteine, die nicht gewebespezifisch sind
PT1650219E (pt) * 1997-10-17 2008-03-31 Genentech Inc Homólogos de toll humana

Also Published As

Publication number Publication date
KR100388860B1 (ko) 2003-06-25
JP2009089713A (ja) 2009-04-30
AU740333B2 (en) 2001-11-01
DE69836630T2 (de) 2007-10-11
EP1798288A2 (en) 2007-06-20
EP1798288B1 (en) 2009-09-16
ATE458053T1 (de) 2010-03-15
CA2289912C (en) 2011-07-26
EP1988166A1 (en) 2008-11-05
HK1112018A1 (en) 2008-08-22
CN101486759A (zh) 2009-07-22
DE69836630D1 (de) 2007-01-25
ES2279572T3 (es) 2007-08-16
PL336635A1 (en) 2000-07-03
CY1109645T1 (el) 2012-05-23
CA2289912A1 (en) 1998-11-12
DK1798288T3 (da) 2010-01-04
ID28299A (id) 2001-05-10
ES2340210T3 (es) 2010-05-31
EP1798288A3 (en) 2007-09-12
JP2006052232A (ja) 2006-02-23
EP0980429A2 (en) 2000-02-23
NO995458L (no) 1999-11-08
ES2331622T3 (es) 2010-01-11
EP1925666B1 (en) 2010-02-17
DK0980429T3 (da) 2007-04-10
DE69841514D1 (de) 2010-04-01
EP1925666A1 (en) 2008-05-28
NZ338073A (en) 2001-09-28
CN1935840A (zh) 2007-03-28
JP2005120106A (ja) 2005-05-12
HK1022175A1 (en) 2000-07-28
PT1798288E (pt) 2009-12-23
WO1998050547A2 (en) 1998-11-12
HK1102720A1 (en) 2007-12-07
NO995458D0 (no) 1999-11-08
IL132614A0 (en) 2001-03-19
CN1263555A (zh) 2000-08-16
AU7175498A (en) 1998-11-27
WO1998050547A3 (en) 1999-03-11
KR20010012323A (ko) 2001-02-15
ATE348157T1 (de) 2007-01-15
CN1225555C (zh) 2005-11-02
JP2002514083A (ja) 2002-05-14
DE69841170D1 (de) 2009-10-29
CN1800214A (zh) 2006-07-12
ATE443139T1 (de) 2009-10-15
EP0980429B1 (en) 2006-12-13

Similar Documents

Publication Publication Date Title
AU740333B2 (en) Human receptor proteins; related reagents and methods
US7271248B2 (en) Human receptor proteins; related reagents and methods
KR100907356B1 (ko) 사람 수용체 단백질, 관련 시약 및 방법
AU2001264889B2 (en) Human receptor proteins; related reagents and methods
AU2001264889A1 (en) Human receptor proteins; related reagents and methods
CZ376299A3 (cs) V podstatě čistý nebo rekombinantní protein DLTR2 2 až 10, fúzní protein, vazebná látka, nukleová kyselina, expresívní vektor, hostitelská buňka a způsob jejich produkce
HK1022175B (en) Human toll-like receptor proteins, related reagents and methods
HK1115900A (en) Human receptor proteins, related reagents and methods
HK1120291A (en) Human toll-like receptor proteins, related reagents and methods
HK1063190A (en) Human receptor proteins, related reagents and methods
HK1095153A (en) Human receptor proteins, related reagents and methods
HK1102720B (en) Human toll-like receptor proteins, related reagents and methods
HK1112018B (en) Human toll-like receptor proteins, related reagents and methods
MXPA99010261A (en) Human toll-like receptor proteins, related reagents and methods